Literature DB >> 35261657

The Implication of Candida Infection in Oral Lichen Planus Lesions.

Ioanina Parlatescu1, Carmen Nicolae1, Serban Tovaru1, Lavinia Radu2, Ovidiu Penes3, Valentin Varlas4.   

Abstract

Objectives: The purpose of this study is to determine if superimposed infection with Candida species in oral lichen planus exacerbates the clinical symptoms and lesions. Methodology:We conducted a retrospective study on the medical charts of oral lichen planus (OLP) patients diagnosed by clinical and histopathological criteria. A baseline demographic, anamnestic, clinical data, results of the oral candida investigations were analyzed and recorded for all patients.
Results: From a total number of 203 OLP patients, oral candidiasis was diagnosed in 75 (36.94%) cases. There was no statistical significance between the clinical forms of lichen planus and the presence of Candida infection. Of all encountered Candida species, Candida albicans was most commonly detected, followed by Candida krusei, Candida lusitaniae, and Candida tropicalis.
Conclusion: Although our study is limited regarding the sample size and no statistically significant difference has been found between clinical features of OLP and oral candidiasis, a routine screening of OLP patients for oral candidiasis and a preventive antifungal strategy in the OLP treatment schedule is needed.

Entities:  

Year:  2021        PMID: 35261657      PMCID: PMC8897806          DOI: 10.26574/maedica.2021.16.4.585

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  14 in total

1.  Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications.

Authors:  E H van der Meij; I van der Waal
Journal:  J Oral Pathol Med       Date:  2003-10       Impact factor: 4.253

Review 2.  Medical treatments for pregnant patients with oral lichen planus.

Authors:  Jiao Wei; Danhua Ma; Min Qiu; Hongxia Dan; Xin Zeng; Lu Jiang; Yu Zhou; Jiayi Wang; Qianming Chen
Journal:  Acta Odontol Scand       Date:  2016-11-09       Impact factor: 2.331

3.  Squamous cell carcinoma development in previously diagnosed oral lichen planus: de novo or transformation?

Authors:  Zheng-Yu Shen; Wei Liu; Jin-Qiu Feng; Hai-Wen Zhou; Zeng-Tong Zhou
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2011-08-24

Review 4.  Association of oral lichen planus with chronic C hepatitis. Review of the data in literature.

Authors:  Carmen Gheorghe; Lelia Mihai; Ioanina Parlatescu; Serban Tovaru
Journal:  Maedica (Buchar)       Date:  2014-03

5.  Oral candidosis in lichen planus: the diagnostic approach is of major therapeutic importance.

Authors:  C Kragelund; L Kieffer-Kristensen; J Reibel; E P Bennett
Journal:  Clin Oral Investig       Date:  2012-06-15       Impact factor: 3.573

6.  Candida in patients with oral lichen planus.

Authors:  I M Lundström; G B Anneroth; K Holmberg
Journal:  Int J Oral Surg       Date:  1984-06

7.  Oral candidiasis following steroid therapy for oral lichen planus.

Authors:  D R Marable; L M Bowers; T L Stout; C M Stewart; K M Berg; V Sankar; S S DeRossi; J R Thoppay; M T Brennan
Journal:  Oral Dis       Date:  2016-01-13       Impact factor: 3.511

8.  Correlation between clinical and pathological features of oral lichen planus: A retrospective observational study.

Authors:  Paula Boñar-Alvarez; Mario Pérez Sayáns; Abel Garcia-Garcia; Cintia Chamorro-Petronacci; Pilar Gándara-Vila; Romina Luces-González; Eva Otero Rey; Andres Blanco-Carrión; J M Suárez-Peñaranda
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.889

Review 9.  Oral lichen planus: a microbiologist point of view.

Authors:  Tomás G Villa; Ángeles Sánchez-Pérez; Carmen Sieiro
Journal:  Int Microbiol       Date:  2021-03-10       Impact factor: 2.479

10.  A pilot study: a possible implication of Candida as an etiologically endogenous pathogen for oral lichen planus.

Authors:  Hong He; Xinyu Xia; Haiping Yang; Qiao Peng; Jiaoer Zheng
Journal:  BMC Oral Health       Date:  2020-03-14       Impact factor: 2.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.